- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/13 - B-cells
Patent holdings for IPC class A61K 40/13
Total number of patents in this class: 59
10-year publication summary
|
0
|
1
|
1
|
2
|
3
|
8
|
1
|
3
|
18
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Dana-Farber Cancer Institute, Inc. | 2645 |
5 |
| Regents of the University of Minnesota | 2773 |
3 |
| BE Biopharma, Inc. | 15 |
3 |
| Centre National de La Recherche Scientifique | 10914 |
2 |
| Children's National Medical Center | 279 |
2 |
| The Cleveland Clinic Foundation | 1584 |
2 |
| Institut Curie | 610 |
2 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3154 |
2 |
| STEMCELL Technologies Canada Inc. | 291 |
2 |
| The University of North Carolina at Chapel Hill | 2078 |
2 |
| Université Paris-saclay | 610 |
2 |
| Université Paris Cité | 885 |
2 |
| Fred Hutchinson Cancer Center | 467 |
2 |
| Novartis AG | 10338 |
1 |
| Massachusetts Institute of Technology | 10204 |
1 |
| Board of Regents, The University of Texas System | 6065 |
1 |
| Tsinghua University | 6128 |
1 |
| University of Florida Research Foundation, Inc. | 4159 |
1 |
| Northwestern University | 3530 |
1 |
| Apeiron Biologics AG | 30 |
1 |
| Other owners | 21 |